Patric Schyman
About Patric Schyman
Patric Schyman is a Principal Scientist at Bristol Myers Squibb in Princeton, New Jersey, with a strong background in toxicogenomics, QSAR, computational chemistry, life sciences, and data analysis.
Current Position at Bristol Myers Squibb
Patric Schyman currently serves as a Principal Scientist at Bristol Myers Squibb. He has been in this role since January 2021 and is based in Princeton, New Jersey, United States. At Bristol Myers Squibb, he brings his expertise in toxicogenomics, QSAR, computational chemistry, life sciences, and data analysis to the forefront of his work.
Previous Experience at DoD Biotechnology HPC Software Applications Institute
Before joining Bristol Myers Squibb, Patric Schyman worked at the Department of Defense (DoD) Biotechnology HPC Software Applications Institute. From 2014 to 2021, he held the position of Research Scientist II in Frederick, MD. During his 7-year tenure, he focused on research and development, contributing to the advancement of biotechnology applications.
Academic Roles at Yale University
Patric Schyman has also been associated with Yale University, where he first served as a Postdoctoral Research Associate from 2011 to 2013. Subsequently, he was promoted to Associate Research Scientist and held this position from 2013 to 2014. Based in New Haven, CT, his work at Yale involved significant research contributions in life sciences and biotechnology.
Postdoctoral Fellowship at The Hebrew University of Jerusalem
From 2008 to 2011, Patric Schyman completed a Postdoctoral Fellowship at The Hebrew University of Jerusalem in Israel. During this 3-year period, he expanded his expertise in computational chemistry and toxicogenomics. This fellowship allowed him to collaborate with diverse researchers and contribute to important scientific studies.
Educational Background in Chemistry and Physics
Patric Schyman's academic journey began at Uppsala University, where he earned a Master of Science (M.S.) in Physics from 1999 to 2003. He continued his studies at Stockholm University, completing a Doctor of Philosophy (PhD) in Chemistry from 2003 to 2008. His strong educational foundation in both chemistry and physics has been integral to his research and professional roles.